Supernus Pharmaceuticals (SUPN) Raw Materials (2012 - 2026)
Supernus Pharmaceuticals' Raw Materials was $22.96 million in Q2 2026, up 172.8% from $8.42 million a year earlier but down 27.0% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Raw Materials (2012 - 2026) Analysis & Trends
At the end of FY2025, Raw Materials at Supernus Pharmaceuticals came in at $31.83 million, up 186.1% from FY2024.
- Raw Materials shows a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
- In earlier years, Raw Materials was $11.13 million in FY2024 (-31.6%), $16.27 million in FY2023 (-34.4%), $24.82 million in FY2022 (+238.8%) and $7.33 million in FY2021 (-67.0%).
- Quarterly Raw Materials has moved between $7.33 million (Q4 2021) and $56.99 million (Q3 2025) over five years.
- Compared with a year earlier, Raw Materials has increased for four straight quarters, with growth averaging 104.5% over the last eight quarters.
- The best year-over-year quarter for Raw Materials over five years was Q3 2025 (growth of 392.5%); the worst was Q2 2022 (a decline of 73.5%).
- Per Business Quant data, SUPN's Raw Materials in the three quarters before Q2 2026 was $31.47 million (Q1 2026), $31.83 million (Q4 2025) and $56.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.96 Mn |
| Mar 31, 2026 | 31.47 Mn |
| Dec 31, 2025 | 31.83 Mn |
| Sep 30, 2025 | 56.99 Mn |
| Jun 30, 2025 | 8.42 Mn |
| Mar 31, 2025 | 8.66 Mn |
| Dec 31, 2024 | 11.13 Mn |
| Sep 30, 2024 | 11.57 Mn |
| Jun 30, 2024 | 15.90 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Dec 31, 2023 | 16.27 Mn |
| Sep 30, 2023 | 21.56 Mn |
| Jun 30, 2023 | 28.16 Mn |
| Mar 31, 2023 | 22.92 Mn |
| Dec 31, 2022 | 24.82 Mn |
| Sep 30, 2022 | 11.01 Mn |
| Jun 30, 2022 | 7.46 Mn |
| Mar 31, 2022 | 9.24 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 9.71 Mn |
API Access
Supernus Pharmaceuticals Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();